These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
336 related articles for article (PubMed ID: 35056557)
1. Gut Dysbiosis and Immune System in Atherosclerotic Cardiovascular Disease (ACVD). Yoo JY; Sniffen S; McGill Percy KC; Pallaval VB; Chidipi B Microorganisms; 2022 Jan; 10(1):. PubMed ID: 35056557 [TBL] [Abstract][Full Text] [Related]
2. Gut macrobiotic and its metabolic pathways modulate cardiovascular disease. Zhu J; Lyu J; Zhao R; Liu G; Wang S Front Microbiol; 2023; 14():1272479. PubMed ID: 37822750 [TBL] [Abstract][Full Text] [Related]
3. The Role of the Gut Microbiome and Trimethylamine Oxide in Atherosclerosis and Age-Related Disease. El Hage R; Al-Arawe N; Hinterseher I Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768722 [TBL] [Abstract][Full Text] [Related]
4. Beneficial Effects of Essential Oils from the Mediterranean Diet on Gut Microbiota and Their Metabolites in Ischemic Heart Disease and Type-2 Diabetes Mellitus. Sánchez-Quintero MJ; Delgado J; Medina-Vera D; Becerra-Muñoz VM; Queipo-Ortuño MI; Estévez M; Plaza-Andrades I; Rodríguez-Capitán J; Sánchez PL; Crespo-Leiro MG; Jiménez-Navarro MF; Pavón-Morón FJ Nutrients; 2022 Nov; 14(21):. PubMed ID: 36364913 [TBL] [Abstract][Full Text] [Related]
5. Role of gut microbiota in chronic low-grade inflammation as potential driver for atherosclerotic cardiovascular disease: a systematic review of human studies. van den Munckhof ICL; Kurilshikov A; Ter Horst R; Riksen NP; Joosten LAB; Zhernakova A; Fu J; Keating ST; Netea MG; de Graaf J; Rutten JHW Obes Rev; 2018 Dec; 19(12):1719-1734. PubMed ID: 30144260 [TBL] [Abstract][Full Text] [Related]
6. Resveratrol Attenuates Trimethylamine-N-Oxide (TMAO)-Induced Atherosclerosis by Regulating TMAO Synthesis and Bile Acid Metabolism via Remodeling of the Gut Microbiota. Chen ML; Yi L; Zhang Y; Zhou X; Ran L; Yang J; Zhu JD; Zhang QY; Mi MT mBio; 2016 Apr; 7(2):e02210-15. PubMed ID: 27048804 [TBL] [Abstract][Full Text] [Related]
7. Importance of gut microbiota metabolites in the development of cardiovascular diseases (CVD). Hemmati M; Kashanipoor S; Mazaheri P; Alibabaei F; Babaeizad A; Asli S; Mohammadi S; Gorgin AH; Ghods K; Yousefi B; Eslami M Life Sci; 2023 Sep; 329():121947. PubMed ID: 37463653 [TBL] [Abstract][Full Text] [Related]
8. Gut Dysbiosis and Cardiovascular Health: A Comprehensive Review of Mechanisms and Therapeutic Potential. Trehan S; Singh G; Bector G; Jain P; Mehta T; Goswami K; Chawla A; Jain A; Puri P; Garg N Cureus; 2024 Aug; 16(8):e67010. PubMed ID: 39280497 [TBL] [Abstract][Full Text] [Related]
9. Exploring the Gut Microbiota and Cardiovascular Disease. Murphy K; O'Donovan AN; Caplice NM; Ross RP; Stanton C Metabolites; 2021 Jul; 11(8):. PubMed ID: 34436434 [TBL] [Abstract][Full Text] [Related]
10. Gut Dysbiosis and Its Associations with Gut Microbiota-Derived Metabolites in Dogs with Myxomatous Mitral Valve Disease. Li Q; Larouche-Lebel É; Loughran KA; Huh TP; Suchodolski JS; Oyama MA mSystems; 2021 Apr; 6(2):. PubMed ID: 33879495 [TBL] [Abstract][Full Text] [Related]
11. Mutual Interplay of Host Immune System and Gut Microbiota in the Immunopathology of Atherosclerosis. Yeh CF; Chen YH; Liu SF; Kao HL; Wu MS; Yang KC; Wu WK Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33227973 [TBL] [Abstract][Full Text] [Related]
12. Bile acid coordinates microbiota homeostasis and systemic immunometabolism in cardiometabolic diseases. Guan B; Tong J; Hao H; Yang Z; Chen K; Xu H; Wang A Acta Pharm Sin B; 2022 May; 12(5):2129-2149. PubMed ID: 35646540 [TBL] [Abstract][Full Text] [Related]
13. METABOLIC DYSBIOSIS OF THE GUT MICROBIOTA AND ITS BIOMARKERS. Sitkin SI; Tkachenko EI; Vakhitov TY Eksp Klin Gastroenterol; 2016 Jul; 12(12):6-29. PubMed ID: 29889418 [TBL] [Abstract][Full Text] [Related]
14. Intestinal microbiota composition modulates choline bioavailability from diet and accumulation of the proatherogenic metabolite trimethylamine-N-oxide. Romano KA; Vivas EI; Amador-Noguez D; Rey FE mBio; 2015 Mar; 6(2):e02481. PubMed ID: 25784704 [TBL] [Abstract][Full Text] [Related]
15. The Role of Gut Microbiota on Cholesterol Metabolism in Atherosclerosis. Vourakis M; Mayer G; Rousseau G Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360839 [TBL] [Abstract][Full Text] [Related]
16. Role of the intestinal microbiome and its therapeutic intervention in cardiovascular disorder. Luqman A; Hassan A; Ullah M; Naseem S; Ullah M; Zhang L; Din AU; Ullah K; Ahmad W; Wang G Front Immunol; 2024; 15():1321395. PubMed ID: 38343539 [TBL] [Abstract][Full Text] [Related]
17. Gut Microbiota in Ischemic Stroke: Role of Gut Bacteria-Derived Metabolites. Zhang W; Dong XY; Huang R Transl Stroke Res; 2023 Dec; 14(6):811-828. PubMed ID: 36279071 [TBL] [Abstract][Full Text] [Related]
18. Gut Microbiota and Heart, Vascular Injury. Zeng C; Tan H Adv Exp Med Biol; 2020; 1238():107-141. PubMed ID: 32323183 [TBL] [Abstract][Full Text] [Related]
19. Gut microbiome and metabolites, the future direction of diagnosis and treatment of atherosclerosis? Cao H; Zhu Y; Hu G; Zhang Q; Zheng L Pharmacol Res; 2023 Jan; 187():106586. PubMed ID: 36460280 [TBL] [Abstract][Full Text] [Related]
20. Short Chain Fatty Acids: Fundamental mediators of the gut-lung axis and their involvement in pulmonary diseases. Ashique S; De Rubis G; Sirohi E; Mishra N; Rihan M; Garg A; Reyes RJ; Manandhar B; Bhatt S; Jha NK; Singh TG; Gupta G; Singh SK; Chellappan DK; Paudel KR; Hansbro PM; Oliver BG; Dua K Chem Biol Interact; 2022 Dec; 368():110231. PubMed ID: 36288778 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]